Portal de Periódicos da CAPES

Differentiating Frontotemporal Dementia From Catatonia: A Complex Neuropsychiatric Challenge

2015; American Psychiatric Association Publishing; Volume: 27; Issue: 2 Linguagem: Inglês

10.1176/appi.neuropsych.14070157

1545-7222

Simon Ducharme, Bradford C. Dickerson, Mykol Larvie, Bruce H. Price,

Treatment of Major Depression

Back to table of contents Previous article Next article DepartmentsFull AccessDifferentiating Frontotemporal Dementia From Catatonia: A Complex Neuropsychiatric ChallengeSimon Ducharme, M.D., M.Sc., Bradford C. Dickerson, M.D., Mykol Larvie, M.D., Ph.D., Bruce H. Price, M.D.Simon Ducharme, M.D., M.Sc., Bradford C. Dickerson, M.D., Mykol Larvie, M.D., Ph.D., Bruce H. Price, M.D.Published Online:29 Apr 2015https://doi.org/10.1176/appi.neuropsych.14070157AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail To the Editor: Symptoms of catatonia,1 including stereotypy, echophenomena, mutism, and perseveration, may overlap with those of behavioral variant frontotemporal dementia (bvFTD), which can lead to mistaken diagnoses.2,3 In addition, catatonia can also be a presenting symptom of bvFTD.4 We report a case with a complex differential diagnosis between persistent residual catatonia symptoms and bvFTD, and we review the approach to this neuropsychiatric challenge.Case ReportA 55-year-old man was evaluated at the Behavioral Neurology and Neuropsychiatry Clinic of McLean Hospital and subsequently at the Frontotemporal Disorders Clinic of the Massachusetts General Hospital for a 3-year history of cognitive decline concerning for bvFTD. The patient graduated from an Ivy League school and worked as a lawyer before the onset of his symptoms. The patient's past psychiatric history was significant for longstanding bipolar I disorder, which was well controlled with lithium. There was a strong family history of bipolar disorder but no frontotemporal dementia (FTD), amyotrophic lateral sclerosis, or early onset dementia.In 2011, the patient was admitted for rapidly progressive glomerulonephritis. Lithium was discontinued, and treatment with prednisone and azathioprine was initiated. The patient recovered kidney function but developed delirium and suicidal thoughts. Olanzapine and lamotrigine were started, with limited response. After the patient received haloperidol, he developed catatonia (immobility, mutism, and negativism), which improved with lorazepam. The collateral report of the patient's functional decline 1–2 years before he developed glomerulonephritis (disorganization at work leading to mistakes) and cognitive impairment with predominant executive dysfunction on neuropsychological testing raised concern regarding progressive dementia, with a working diagnosis of possible FTD.The patient subsequently had multiple episodes of depression, with suicidal thoughts alternating with retarded catatonia. Eighteen months after the glomerulonephritis, he was hospitalized in a community hospital for acute confusion and aphasia (paraphasias and word-finding problems). A brain MRI scan showed no acute abnormality. A routine EEG was normal. Repeat neuropsychological testing revealed executive dysfunction, including impairments on word-list generation. Aphasic symptoms improved within a few days. However, in light of persisting functional and cognitive decline, the patient was discharged with a final diagnosis of FTD.On our initial assessment, the patient and his wife acknowledged persistence, but denied progression, of cognitive deficits. He had failed to resume his law practice and was caught driving through red lights a few times. His wife reported apathy and a new simple stereotypical breathing sound but no disinhibition, socially inappropriate behavior, or hyperorality. There was no change in empathy, but she described a longstanding history of social awkwardness, visuospatial weaknesses, and clumsiness. He had adequate social comportment. The patient's forward digit span was 8, but his backward digit span was only 3. He scored 26 on 30 on the Montreal Cognitive Assessment (z score=0.5), losing most points on visuospatial tasks. His Frontal Assessment Battery was impaired at 9 on 18 (z score=−9.4), including decreased verbal fluency (phonemic 6, semantic 13) and impaired go/no go. Language was relatively preserved. On neurological examination, the patient had mild motor perseveration and psychomotor slowness but no frank catatonic features such as mutism or waxy flexibility. Six months later, the patient was more apathetic, made occasional paraphasic errors, and had more pronounced fluency deficits (named two animals in 1 minute). His cognitive deficits were too severe to be solely explained by a chronic bipolar disorder. The differential diagnosis was between bvFTD and residual symptoms of catatonia. Atypical features for bvFTD included good insight and fluctuations of language symptoms. Developmental nonverbal learning weaknesses were a potential contributor.A biochemical workup including a paraneoplastic panel was normal. A CSF analysis showed normal cell counts and mildly low Aβ42 (272 pg/mL) but normal P-tau (28.6 pg/mL). A brain MRI scan showed mild diffuse volume loss, with no predominant frontal or anterior temporal atrophy and no change over an 18-month period (Figure 1 [A]). Fluorodeoxyglucose–positron emission tomography showed no definite regional cerebral cortical hypometabolism to suggest a specific neurodegenerative process such as FTD or Alzheimer's disease. There was subtle patchy hypometabolism in the frontal, temporal, and parietal lobes, which was of uncertain clinical significance (Figure 1 [B]).FIGURE 1. [A] An Axial Fluid-Attenuated Inversion Recovery MRI Scan Demonstrating Mild Diffuse Brain Parenchymal Volume Loss With No Regional Predominance, and [B] A Brain Fluorodeoxyglucose–Positron Emission Tomography Scan Showing No Definite Regional Cerebral Cortical HypometabolismAfter 1 year of treatment with divalproex sodium and 4 mg of lorazepam daily, the patient's mood stabilized with no recurrence of catatonia. He was not able to resume working, but he regained independence for all instrumental activities of daily living. At the last follow-up, there were no persistent language deficits or behavioral symptoms. The patient's Frontal Assessment Battery score improved to 13 of 18 (z score=−5; 44% improvement). His fluency remained impaired but improved (phonemic 5, semantic 11). The remission of behavioral symptoms, improvement of executive functions, and neuroimaging results were incompatible with bvFTD. In retrospect, behavioral symptoms and acute aphasia were attributed to fluctuating catatonic states in the context of unstable bipolar I disorder after a medical illness.DiscussionAs illustrated by this case, there can be phenotypic overlap between catatonia and bvFTD, suggesting shared frontostriatal dysfunction.5 In addition, decreased verbal output and stereotypical repetition due to catatonia can be confused with aphasia. Verbal fluency/generation was the main cognitive deficit in our patient, a function that is mediated by the dorsal medial frontal system.6 Of interest, one functional MRI study linked catatonia to abnormalities of this area.7Longitudinal history, response to treatment, and neuroimaging help to establish the correct diagnosis. Catatonia is much more likely to fluctuate over time in parallel to the underlying causative disorder (e.g., bipolar disorder), whereas the course of bvFTD is one of inexorable progressive deterioration. Along the same line, rapid improvement of cognitive symptoms after lorazepam administration would suggest catatonia.Changes on imaging can be subtle in the early stages of bvFTD; however, neuroimaging correlates are expected when a patient has late-stage symptoms such as mutism and immobility. A normal MRI scan in the presence of severe symptoms would favor a diagnosis of catatonia. Small studies have described frontoparietal hypometabolism/hypoperfusion in catatonia,8,9 which is potentially reversible after treatment.9 As our case suggests, a mildly abnormal positron emission tomography scan does not exclude catatonia secondary to a primary psychiatric disorder.In our patient, executive function deficits (most severely generation) persisted despite long-term mood stability. There is one report of persisting cognitive deficits after remission of catatonia,10 and our case adds to this literature. We postulate that partial remission, or persistent cognitive symptoms, of catatonia could explain some cases of nonprogressive bvFTD "phenocopies."From the Behavioral Neurology and Neuropsychiatry Clinic (SD, BHP), Dept. of Neurology, McLean Hospital, Belmont, MA; Depts. of Psychiatry (SD), Neurology (SD, BCD, BHP), and Radiology (ML), Massachusetts General Hospital, Harvard Medical School, Boston, MA; Dept. of Psychiatry (SD), McGill University Health Centre, Montreal, Canada; and McConnell Brain Imaging Centre (SD), Montreal Neurological Institute, Montreal, Canada.Send correspondence to Simon Ducharme, M.D., M.Sc.; e-mail: [email protected]This case was presented in poster format at the 24th annual meeting of the American Neuropsychiatric Association, Boston, MA, April 3–6, 2013.Dr. Ducharme's fellowship was supported by the Sidney R. Baer Jr., Foundation, the Fonds de Recherche du Québec-Santé, and the McGill University Health Centre Research Institute (Frank McGill Travel Fellowship).Dr. Dickerson has served as a consultant for Pfizer, Inc., and En Vivo, Inc. The other authors report no competing interests.The authors thank the patient and his family for their participation, without which this work would not have been possible.References1 Fink M, Taylor MA: The catatonia syndrome: forgotten but not gone. Arch Gen Psychiatry 2009; 66:1173–1177Crossref, Medline, Google Scholar2 Kagan J, Sewell RA, Price B, et al.: The differentiation of frontotemporal dementia from catatonia in a 43-year-old woman: case report. McLean Ann Behav Neurol 2007; 2:5–10Google Scholar3 Suzuki K, Takano T, Matsuoka H: A case of catatonia resembling frontotemporal dementia and resolved with electroconvulsive therapy. World J Biol Psychiatry 2009; 10:245–247Crossref, Medline, Google Scholar4 Holm AC: Neurodegenerative and psychiatric overlap in frontotemporal lobar degeneration: a case of familial frontotemporal dementia presenting with catatonia. Int Psychogeriatr 2014; 26:345–347Crossref, Medline, Google Scholar5 Northoff G, Kötter R, Baumgart F, et al.: Orbitofrontal cortical dysfunction in akinetic catatonia: a functional magnetic resonance imaging study during negative emotional stimulation. Schizophrenia Bull 2004; 30:405–427Crossref, Medline, Google Scholar6 Stuss DT, Alexander MP: Is there a dysexecutive syndrome? Philos Trans R Soc Lond B Biol Sci 2007; 362:901–915Crossref, Medline, Google Scholar7 Scheuerecker J, Ufer S, Käpernick M, et al.: Cerebral network deficits in post-acute catatonic schizophrenic patients measured by fMRI. J Psychiatr Res 2009; 43:607–614Crossref, Medline, Google Scholar8 Northoff G, Steinke R, Nagel DCzerwenka C, et al.: Right lower prefronto-parietal cortical dysfunction in akinetic catatonia: a combined study of neuropsychology and regional cerebral blood flow. Psychol Med 2000; 30:583–596Crossref, Medline, Google Scholar9 De Tiége X, Laureys S, Goldman S, et al.: Regional cerebral glucose metabolism in akinetic catatonia and after remission. J Neurol Neurosurg Psychiatry 2003; 74:1003–1004Crossref, Medline, Google Scholar10 Baker IW, Jackson M, Bass C: Catatonia causing permanent cognitive impairment: a case study. Cogn Behav Neurol 2005; 18:141–143Crossref, Medline, Google Scholar FiguresReferencesCited byDetailsCited ByHow to differentiate behavioral variant frontotemporal dementia from primary psychiatric disorders: practical aspects for the clinician1 May 2022 | Arquivos de Neuro-Psiquiatria, Vol. 80, No. 5 suppl 1Case Report: Catatonic Stupor in Behavioral Variant Frontotemporal Dementia18 January 2022 | Frontiers in Neurology, Vol. 12Clinical features and predictors of non-response in severe catatonic patients treated with electroconvulsive therapy12 August 2021 | International Journal of Psychiatry in Clinical Practice, Vol. 25, No. 3Crossing Borders Between Frontotemporal Dementia and Psychiatric Disorders: An Updated OverviewJournal of Alzheimer's Disease, Vol. 75, No. 2Treatment of Catatonia in Frontotemporal Dementia: A Lesson From Zolpidem TestClinical Neuropharmacology, Vol. 42, No. 5Neuropathology, Vol. 38, No. 3L'Encéphale, Vol. 43, No. 5Psychiatry Research, Vol. 255Journal of Alzheimer's Disease, Vol. 51, No. 4 Volume 27Issue 2 Spring 2015Pages e174-e176 Metrics The authors thank the patient and his family for their participation, without which this work would not have been possible.PDF download History Published online 29 April 2015 Published in print 1 April 2015